1 |
Koizumi A, Kobayashi H, Hitomi T, Harada KH, Habu T, Youssefian S. A new horizon of moyamoya disease and associated health risks explored through RNF213. Environ Health Prev Med 2016;21:55-70.
DOI
|
2 |
Bang OY, Chung JW, Kim DH, et al. Moyamoya disease and spectrums of RNF213 vasculopathy. Transl Stroke Res 2020;11:580-9.
DOI
|
3 |
Kim HJ, Jo WM, Rhu SM, Hwang JJ, Sohn YS, Choi YH. Coronary artery disease affected by moyamoya disease. Korean J Thorac Cardiovasc Surg 2002;35:231-4.
|
4 |
Guo DC, Papke CL, Tran-Fadulu V, et al. Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am J Hum Genet 2009;84:617-27.
DOI
|
5 |
Nam TM, Jo KI, Yeon JY, Hong SC, Kim JS. Coronary heart disease in moyamoya disease: are they concomitant or coincidence? J Korean Med Sci 2015;30:470-4.
DOI
|
6 |
Choi W, Kim YN, Kim KH. Variant angina in moyamoya disease: a correlative etiology and different presentation: a case report. J Med Case Rep 2015;9:86.
DOI
|
7 |
Takaoka K, Yoshimura M, Ogawa H, et al. Comparison of the risk factors for coronary artery spasm with those for organic stenosis in a Japanese population: role of cigarette smoking. Int J Cardiol 2000;72:121-6.
DOI
|
8 |
Tanabe Y, Itoh E, Suzuki K, et al. Limited role of coronary angioplasty and stenting in coronary spastic angina with organic stenosis. J Am Coll Cardiol 2002;39:1120-6.
DOI
|